U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750587) titled 'Predicting Response and Exposure Changes in Cirrhosis for Effectiveness' on Aug. 03.
Brief Summary: The goal of this clinical trial is to learn how liver cirrhosis affects the way the body processes drugs in adults with different stages of liver cirrhosis. This information may help improve drug dosing for people with liver cirrhosis in the future. The main question it aims to answer is:
* How does the severity of liver cirrhosis affect the way the body processes a combination of five drugs, each used to measure the activity of a different liver enzyme?
Researchers will compare participants with mild, moderate, and severe liver cirr...